BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36866391)

  • 1. Selective disruption of NRF2-KEAP1 interaction leads to NASH resolution and reduction of liver fibrosis in mice.
    Seedorf K; Weber C; Vinson C; Berger S; Vuillard LM; Kiss A; Creusot S; Broux O; Geant A; Ilic C; Lemaitre K; Richard J; Hammoutene A; Mahieux J; Martiny V; Durand D; Melchiore F; Nyerges M; Paradis V; Provost N; Duvivier V; Delerive P
    JHEP Rep; 2023 Apr; 5(4):100651. PubMed ID: 36866391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease.
    Jiao J; Sanchez JI; Saldarriaga OA; Solis LM; Tweardy DJ; Maru DM; Stevenson HL; Beretta L
    JHEP Rep; 2023 Feb; 5(2):100628. PubMed ID: 36687470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific targeting of the NRF2/β-TrCP axis promotes beneficial effects in NASH.
    Fernández-Ginés R; Encinar JA; Escoll M; Carnicero-Senabre D; Jiménez-Villegas J; García-Yagüe ÁJ; González-Rodríguez Á; Garcia-Martinez I; Valverde ÁM; Rojo AI; Cuadrado A
    Redox Biol; 2024 Feb; 69():103027. PubMed ID: 38184999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hepatic p63 ameliorates steatohepatitis with fibrosis in mice.
    Fondevila MF; Novoa E; Fernandez U; Dorta V; Parracho T; Kreimeyer H; Garcia-Vence M; Chantada-Vazquez MP; Bravo SB; Porteiro B; Cabaleiro A; Koning M; Senra A; Souto Y; Verheij J; Guallar D; Fidalgo M; Meijnikman AS; da Silva Lima N; Dieguez C; Gonzalez-Rellan MJ; Nogueiras R
    Mol Metab; 2024 May; 85():101962. PubMed ID: 38815625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol targeting NRF2 disrupts the binding between KEAP1 and NRF2-DLG motif to ameliorate oxidative stress damage in mice pulmonary infection.
    Chi F; Cheng C; Zhang M; Su B; Hou Y; Bai G
    J Ethnopharmacol; 2024 Oct; 332():118353. PubMed ID: 38762209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periodontal pathogen Fusobacterium nucleatum infection accelerates hepatic steatosis in high-fat diet-fed ApoE knockout mice by inhibiting Nrf2/Keap1 signaling.
    Wu P; Bie M; Zhou J; Wang J; Zhao L
    J Periodontal Res; 2024 May; ():. PubMed ID: 38795023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Nrf2 Signaling.
    Li R; Jia Z; Zhu H
    React Oxyg Species (Apex); 2019 Nov; 8(24):312-322. PubMed ID: 31692987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2 activation reprograms macrophage intermediary metabolism and suppresses the type I interferon response.
    Ryan DG; Knatko EV; Casey AM; Hukelmann JL; Dayalan Naidu S; Brenes AJ; Ekkunagul T; Baker C; Higgins M; Tronci L; Nikitopolou E; Honda T; Hartley RC; O'Neill LAJ; Frezza C; Lamond AI; Abramov AY; Arthur JSC; Cantrell DA; Murphy MP; Dinkova-Kostova AT
    iScience; 2022 Feb; 25(2):103827. PubMed ID: 35198887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel crosstalk between Nrf2 and Smad2/3 bridged by two nuanced Keap1 isoforms with their divergent effects on these distinct family transcription factors.
    Chen F; Wang Q; Xiao M; Lou D; Wufur R; Hu S; Zhang Z; Wang Y; Zhang Y
    Free Radic Biol Med; 2024 Mar; 213():190-207. PubMed ID: 38242246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NASH triggers cardiometabolic HFpEF in aging mice.
    Kucsera D; Ruppert M; Sayour NV; Tóth VE; Kovács T; Hegedűs ZI; Onódi Z; Fábián A; Kovács A; Radovits T; Merkely B; Pacher P; Ferdinandy P; Varga ZV
    Geroscience; 2024 Apr; ():. PubMed ID: 38630423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecules inhibiting Keap1-Nrf2 protein-protein interactions: a novel approach to activate Nrf2 function.
    Zhuang C; Wu Z; Xing C; Miao Z
    Medchemcomm; 2017 Feb; 8(2):286-294. PubMed ID: 30108745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9-Based Screening of FDA-Approved Drugs for NRF2 Activation: A Novel Approach to Discover Therapeutics for Non-Alcoholic Fatty Liver Disease.
    Li J; Arest S; Olszowy B; Gordon J; Barrero CA; Perez-Leal O
    Antioxidants (Basel); 2023 Jun; 12(7):. PubMed ID: 37507903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methionine redox regulation of actin-interacting proteins primarily governs antioxidative signaling and response to the salvianolic acid B treatment in EA.hy926 cells.
    Wang AC; Qi XM; Li QF; Feng YJ; Zhang YL; Wei HZ; Li JS; Qiao YB; Li QS
    Toxicol Appl Pharmacol; 2024 Feb; 483():116835. PubMed ID: 38272317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methyl and Fluorine Effects in Novel Orally Bioavailable Keap1-Nrf2 PPI Inhibitor.
    Otake K; Ubukata M; Nagahashi N; Ogawa N; Hantani Y; Hantani R; Adachi T; Nomura A; Yamaguchi K; Maekawa M; Mamada H; Motomura T; Sato M; Harada K
    ACS Med Chem Lett; 2023 May; 14(5):658-665. PubMed ID: 37197451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring the Redox Status in Multiple Sclerosis.
    Tanaka M; Vécsei L
    Biomedicines; 2020 Oct; 8(10):. PubMed ID: 33053739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcription factor ZNF469 regulates collagen production in liver fibrosis.
    Steinhauser S; Estoppey D; Buehler DP; Xiong Y; Pizzato N; Rietsch A; Wu F; Leroy N; Wunderlin T; Claerr I; Tropberger P; Müller M; Davison LM; Sheng Q; Bergling S; Wild S; Moulin P; Liang J; English WJ; Williams B; Knehr J; Altorfer M; Reyes A; Mickanin C; Hoepfner D; Nigsch F; Frederiksen M; Flynn CR; Fodor BD; Brown JD; Kolter C
    bioRxiv; 2024 Apr; ():. PubMed ID: 38712281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nrf2-Keap1 in Cardiovascular Disease: Which is the Cart and Which the Horse?
    Dhyani NH; Tian C; Gao L; Rudebush TL; Zucker IH
    Physiology (Bethesda); 2024 Apr; ():. PubMed ID: 38687468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is Known Regarding the Participation of Factor Nrf-2 in Liver Regeneration?
    Morales-González JA; Madrigal-Santillán E; Morales-González Á; Bautista M; Gayosso-Islas E; Sánchez-Moreno C
    Cells; 2015 May; 4(2):169-77. PubMed ID: 26010752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomics of human NAFLD: Lack of data reproducibility and high interpatient variability in drug target expression as major causes of drug failures.
    Tang S; Borlak J
    Hepatology; 2024 Feb; ():. PubMed ID: 38358517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melissa officinalis extract palliates redox imbalance and inflammation associated with hyperthyroidism-induced liver damage by regulating Nrf-2/ Keap-1 gene expression in γ-irradiated rats.
    Kawara RS; Moawed FS; Elsenosi Y; Elmaksoud HA; Ahmed ESA; Abo-Zaid OA
    BMC Complement Med Ther; 2024 Feb; 24(1):71. PubMed ID: 38303002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.